Results

Total Results: 3,620 records

Showing results for "infant mortality".

  1. www.ahrq.gov/hai/cusp/clabsi-neonatal/nclabsi4.html
    January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention Results Previous Page Next Page Table of Contents Eliminating CLABSI, A National Patient Safety Imperative: Neonatal CLABSI Prevention Executive Summary Introduction & Objectives Methods Data Collection and …
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/zk8YxjaQxLGUTtt__nBQB_
    September 09, 2021 - Depression and Suicide Risk Screening: Updated Evidence Summary and Systematic Review for the US Preventive Services Task Force Depression and Suicide Risk Screening Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Elizabeth A. O’Connor, PhD; Leslie A. Perdue, MPH; Erin L. Coppo…
  3. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
    May 01, 2020 - CER 226: Evidence summary_Labor Dystocia Purpose of Review To review the evidence on the definition of “normal” labor progression and the comparative effectiveness of different strategies for treating labor dystocia in women with otherwise uncomplicated pregnancies. Strategies assessed include amniotomy, suppo…
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
    May 01, 2020 - CER 226: Evidence summary_Labor Dystocia Purpose of Review To review the evidence on the definition of “normal” labor progression and the comparative effectiveness of different strategies for treating labor dystocia in women with otherwise uncomplicated pregnancies. Strategies assessed include amniotomy, suppo…
  5. effectivehealthcare-admin.ahrq.gov/products/insulin-blood-sugar-2010/research-protocol
    December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    August 22, 2023 - fumarate alone and placebo in pregnancy rate, risk of preterm birth, congenital anomalies, or postpartum infantmortality. 46 There were no differences between the dapivirine vaginal ring and placebo in incidence
  7. www.uspreventiveservicestaskforce.org/home/getfilebytoken/6fFns4N2J-t5EGC5BUdRuu
    October 23, 2023 - marate alone and placebo in pregnancy rate, risk of preterm birth, congenital anomalies, or postpartum infantmortality.46 There were no differences between the dapivirine vaginal ring and placebo in incidence
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/MWRHULpw6y_5Uk_KXTyvp8
    January 10, 2017 - Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review Copyright 2016 American Medical Association. All rights reserved. Folic Acid Supplementation for the Prevention of Neural Tube Defects An Updated Evidence Report and Systematic Review for the US Pre…
  9. www.ahrq.gov/sites/default/files/2024-09/rogers-report.pdf
    January 01, 2024 - Final Progress Report: Staff Nurse Fatigue and Patient Safety Staff Nurse Fatigue and Patient Safety Principal Investigator: Ann E. Rogers, PhD, RN Co-Investigators: Linda Aiken, PhD, RN David Dinges, PhD Wei-ting Hwang, PhD Linda D. Scott, PhD, RN Organization: University of Pennsylvania School of Nursi…
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chlamydia-and-gonorrhea-screening
    September 14, 2021 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Chlamydia and Gonorrhea: Screening September 14, 2021 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as …
  11. hcup-us.ahrq.gov/reports/statbriefs/sb193-Neonatal-Maternal-Hospitalizations-Substance-Use.jsp
    July 01, 2015 - Neonatal and Maternal Hospital Stays Related to Substance Use, 2006-2012 #193 An official website of the Department of Health & Human Services Search All AHRQ Websites Careers Contact Us …
  12. ce.effectivehealthcare.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
    January 01, 2024 - Final Progress Report: Improving Medication Safety Across Clinical Settings FINAL REPORT: November 29, 2007 Improving Medication Safety Across Clinical Settings Principal Investigator: David W. Bates; dbates@…
  13. www.ahrq.gov/sites/default/files/2024-01/bates-report.pdf
    January 01, 2024 - Final Progress Report: Improving Medication Safety Across Clinical Settings FINAL REPORT: November 29, 2007 Improving Medication Safety Across Clinical Settings Principal Investigator: David W. Bates; dbates@…
  14. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-154-fullreport.pdf
    July 01, 2018 - Continuity of Insurance: Coverage Presumed Eligible 1 Continuity of Insurance: Coverage Presumed Eligible Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Coverage Presumed Eligible 1.B. Measure Number 0154 1.C. Measure Description Please provide a non-technical descripti…
  15. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
    September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible 1 Continuity of Insurance: Coverage Presumed Ineligible Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Coverage Presumed Ineligible 1.B. Measure Number 0155 1.C. Measure Description Please provide a non-technical d…
  16. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-fullreport.pdf
    September 01, 2018 - Continuity of Insurance: Coverage Presumed Ineligible 1 Continuity of Insurance: Coverage Presumed Ineligible Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Coverage Presumed Ineligible 1.B. Measure Number 0155 1.C. Measure Description Please provide a non-technical d…
  17. www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
    June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment 1 Continuity of Insurance: Duration of First Observed Enrollment Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Duration of First Observed Enrollment 1.B. Measure Number 0156 1.C. Measure Description Please …
  18. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
    June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment 1 Continuity of Insurance: Duration of First Observed Enrollment Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Duration of First Observed Enrollment 1.B. Measure Number 0156 1.C. Measure Description Please …
  19. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-fullreport.pdf
    June 01, 2018 - Continuity of Insurance: Duration of First Observed Enrollment 1 Continuity of Insurance: Duration of First Observed Enrollment Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Duration of First Observed Enrollment 1.B. Measure Number 0156 1.C. Measure Description Please …
  20. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-fullreport.pdf
    May 23, 2018 - Continuity of Insurance: Informed Participation 1 Continuity of Insurance: Informed Participation Section 1. Basic Measure Information 1.A. Measure Name Continuity of Insurance: Informed Participation 1.B. Measure Number 0153 1.C. Measure Description Please provide a non-technical description of the me…